Search

James Henry Alstrum Acevedo

Supervisory Patent Examiner (ID: 1840, Phone: (571)272-5548 , Office: P/1675 )

Most Active Art Unit
1616
Art Unit(s)
1654, 1675, 1622, 1616
Total Applications
713
Issued Applications
223
Pending Applications
99
Abandoned Applications
394

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7045206 [patent_doc_number] => 20050249801 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Stabilization of solid drug formulations' [patent_app_type] => utility [patent_app_number] => 11/184341 [patent_app_country] => US [patent_app_date] => 2005-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5984 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249801.pdf [firstpage_image] =>[orig_patent_app_number] => 11184341 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/184341
Stabilization of solid drug formulations Jul 18, 2005 Abandoned
Array ( [id] => 5799150 [patent_doc_number] => 20060034776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics' [patent_app_type] => utility [patent_app_number] => 11/182382 [patent_app_country] => US [patent_app_date] => 2005-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14459 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034776.pdf [firstpage_image] =>[orig_patent_app_number] => 11182382 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/182382
Inhalable medicaments containing a new anticholinergic, corticosteroids, and betamimetics Jul 14, 2005 Abandoned
Array ( [id] => 5799149 [patent_doc_number] => 20060034775 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-16 [patent_title] => 'Aerosol formulation for inhalation containing an anticholinergic' [patent_app_type] => utility [patent_app_number] => 11/181517 [patent_app_country] => US [patent_app_date] => 2005-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4023 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20060034775.pdf [firstpage_image] =>[orig_patent_app_number] => 11181517 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/181517
Aerosol formulation for inhalation containing an anticholinergic Jul 13, 2005 Abandoned
Array ( [id] => 5766596 [patent_doc_number] => 20060018840 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Aerosolizable formulation comprising nicotine' [patent_app_type] => utility [patent_app_number] => 11/169153 [patent_app_country] => US [patent_app_date] => 2005-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10850 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018840.pdf [firstpage_image] =>[orig_patent_app_number] => 11169153 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/169153
Aerosolizable formulation comprising nicotine Jun 27, 2005 Abandoned
Array ( [id] => 6977362 [patent_doc_number] => 20050287078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-29 [patent_title] => 'Minimizing powder retention on surfaces' [patent_app_type] => utility [patent_app_number] => 11/154692 [patent_app_country] => US [patent_app_date] => 2005-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 10254 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20050287078.pdf [firstpage_image] =>[orig_patent_app_number] => 11154692 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/154692
Minimizing powder retention on surfaces Jun 16, 2005 Abandoned
Array ( [id] => 4442582 [patent_doc_number] => 07928144 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-19 [patent_title] => 'Antiinflammatory and analgesic preparation for external use' [patent_app_type] => utility [patent_app_number] => 11/629367 [patent_app_country] => US [patent_app_date] => 2005-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6118 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/928/07928144.pdf [firstpage_image] =>[orig_patent_app_number] => 11629367 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/629367
Antiinflammatory and analgesic preparation for external use Jun 14, 2005 Issued
Array ( [id] => 4791589 [patent_doc_number] => 20080292562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts' [patent_app_type] => utility [patent_app_number] => 11/572199 [patent_app_country] => US [patent_app_date] => 2005-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9260 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20080292562.pdf [firstpage_image] =>[orig_patent_app_number] => 11572199 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/572199
Medicaments For Inhalation Comprising Pde IV Inhibitors and Enantiomerically Pure Glycopyrrolate Salts Jun 12, 2005 Abandoned
Array ( [id] => 5210914 [patent_doc_number] => 20070249498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-25 [patent_title] => 'Method of Applying Pesticides' [patent_app_type] => utility [patent_app_number] => 11/569754 [patent_app_country] => US [patent_app_date] => 2005-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5362 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20070249498.pdf [firstpage_image] =>[orig_patent_app_number] => 11569754 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/569754
Method of applying pesticides Jun 8, 2005 Issued
Array ( [id] => 6951807 [patent_doc_number] => 20050226901 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Dermatological composition' [patent_app_type] => utility [patent_app_number] => 11/142332 [patent_app_country] => US [patent_app_date] => 2005-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 9819 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20050226901.pdf [firstpage_image] =>[orig_patent_app_number] => 11142332 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/142332
Method of protecting skin from UV radiation using a dermatological composition having porous silicon Jun 1, 2005 Issued
Array ( [id] => 5013479 [patent_doc_number] => 20070256687 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-08 [patent_title] => 'Enhanced Medical Product' [patent_app_type] => utility [patent_app_number] => 11/629803 [patent_app_country] => US [patent_app_date] => 2005-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7074 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20070256687.pdf [firstpage_image] =>[orig_patent_app_number] => 11629803 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/629803
Enhanced Medical Product May 31, 2005 Abandoned
Array ( [id] => 4669428 [patent_doc_number] => 20080044488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'Nano Glass Powder and Use Thereof, in Particular Multicomponent Glass Powder with a Mean Particle Size of Less Than 1 µm' [patent_app_type] => utility [patent_app_number] => 11/597959 [patent_app_country] => US [patent_app_date] => 2005-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4990 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20080044488.pdf [firstpage_image] =>[orig_patent_app_number] => 11597959 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/597959
Nano glass powder and use thereof, in particular multicomponent glass powder with a mean particle size of less than 1 μm May 24, 2005 Issued
Array ( [id] => 5622101 [patent_doc_number] => 20060260606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-23 [patent_title] => 'Inhalable formulations of amphotericin B and methods and devices for delivery thereof' [patent_app_type] => utility [patent_app_number] => 11/131964 [patent_app_country] => US [patent_app_date] => 2005-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3691 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20060260606.pdf [firstpage_image] =>[orig_patent_app_number] => 11131964 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/131964
Inhalable formulations of amphotericin B and methods and devices for delivery thereof May 17, 2005 Abandoned
Array ( [id] => 4859036 [patent_doc_number] => 20080267886 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists' [patent_app_type] => utility [patent_app_number] => 11/568559 [patent_app_country] => US [patent_app_date] => 2005-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9943 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267886.pdf [firstpage_image] =>[orig_patent_app_number] => 11568559 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/568559
Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists May 16, 2005 Abandoned
Array ( [id] => 7225041 [patent_doc_number] => 20050255050 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Powder formulations for inhalation, comprising enantiomerically pure beta agonists' [patent_app_type] => utility [patent_app_number] => 11/128141 [patent_app_country] => US [patent_app_date] => 2005-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10799 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20050255050.pdf [firstpage_image] =>[orig_patent_app_number] => 11128141 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/128141
Powder formulations for inhalation, comprising enantiomerically pure beta agonists May 11, 2005 Abandoned
Array ( [id] => 5904481 [patent_doc_number] => 20060046962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-02 [patent_title] => 'Absorption enhancers for drug administration' [patent_app_type] => utility [patent_app_number] => 11/127786 [patent_app_country] => US [patent_app_date] => 2005-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16480 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20060046962.pdf [firstpage_image] =>[orig_patent_app_number] => 11127786 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/127786
Absorption enhancers for drug administration May 10, 2005 Abandoned
Array ( [id] => 4909282 [patent_doc_number] => 20080020048 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-24 [patent_title] => 'Treatment of Respiratory Disease' [patent_app_type] => utility [patent_app_number] => 11/587718 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3509 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0020/20080020048.pdf [firstpage_image] =>[orig_patent_app_number] => 11587718 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/587718
Treatment of Respiratory Disease May 9, 2005 Abandoned
Array ( [id] => 7233622 [patent_doc_number] => 20050256115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-17 [patent_title] => 'Aerosol formulation for the inhalation of beta-agonists' [patent_app_type] => utility [patent_app_number] => 11/125756 [patent_app_country] => US [patent_app_date] => 2005-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15837 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20050256115.pdf [firstpage_image] =>[orig_patent_app_number] => 11125756 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/125756
Aerosol formulation for the inhalation of beta-agonists May 9, 2005 Abandoned
Array ( [id] => 7045081 [patent_doc_number] => 20050249676 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Pullulan capsules' [patent_app_type] => utility [patent_app_number] => 11/121226 [patent_app_country] => US [patent_app_date] => 2005-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6552 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20050249676.pdf [firstpage_image] =>[orig_patent_app_number] => 11121226 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/121226
Pullulan capsules May 2, 2005 Abandoned
Array ( [id] => 5766936 [patent_doc_number] => 20060018940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-26 [patent_title] => 'Stabilized antimicrobial composition' [patent_app_type] => utility [patent_app_number] => 11/117625 [patent_app_country] => US [patent_app_date] => 2005-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8981 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20060018940.pdf [firstpage_image] =>[orig_patent_app_number] => 11117625 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/117625
Stabilized antimicrobial composition Apr 27, 2005 Abandoned
Array ( [id] => 8363272 [patent_doc_number] => 08252334 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Dry powder pharmaceutical compositions comprising surfactants, hydrophobic active principles, and water-soluble excipients, process of preparing, and stable aqueous suspensions thereof' [patent_app_type] => utility [patent_app_number] => 11/578661 [patent_app_country] => US [patent_app_date] => 2005-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 8933 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11578661 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/578661
Dry powder pharmaceutical compositions comprising surfactants, hydrophobic active principles, and water-soluble excipients, process of preparing, and stable aqueous suspensions thereof Apr 20, 2005 Issued
Menu